Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
Next-generation medicines
Science of eradication
Products for vulnerable populations
Working with regulators
Information for scientists
TPPs & TCPs
Call for proposals
Open source research
Exploiting the Pathogen Box
The Pathogen Box
Open source drug discovery
Open access Malaria Box
Project of the year award
Computational chemistry
Global health compound design webinars
R&D challenges
Access
Products & projects
Product maps
MMV-supported medicines map
Artesun® map
ASAQ Winthrop® map
ASMQ map
Coartem®
Dispersible
map
Eurartesim® map
Pyramax® map
SPAQ map
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Tool Kits
Injectable artesunate tool kit
Rectal artesunate tool kit
Seasonal Malaria Chemoprevention Tool Kit
Access challenges
Partnering
Our partner network
The PDP model
Socially responsible agreements
Our donors
Donate to MMV
Donor stories
First pledges by donors
Our clinical centre partners
Our impact
Achievements
Real life stories
The road to health impact
Impact of the global malaria community
About us
Our mission & vision
Our team
Staff interviews
Staff map
Jobs
MMV's internship programme
What MMV interns say
What MMV fellows say
RFPs/RFIs
Organization and governance
Board of Directors
MMV North America Inc. Board
Access & Product Management Advisory Committee (APMAC)
Expert Scientific Advisory Committee (ESAC)
Global Safety Board
Our policies
Our funding and expenditure
Our history
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Optimizing artemisinin production
Malaria online course
Newsroom
Boilerplate
News
Press releases
Films
Infographics
Interviews
Image slideshows
Publications
Audio
Events
Upcoming events
Past events
Event presentations
Home
Newsroom
Publications
Publications
Filter
All
Access article / report
Advocacy article
External publication
Financing / policy report
Graphic novel
Malaria Box article
MMV Annual Report
MMV general
MMV issues in focus
Pathogen Box article
Scientific article
Series
All
Access article / report
Advocacy article
External publication
Financing / policy report
Graphic novel
Malaria Box article
MMV Annual Report
MMV general
MMV issues in focus
Pathogen Box article
Scientific article
Series
500 found
Mothers and children first: rethinking malaria drug development
07 Aug 2017
Antimalarial drug resistance: linking
Plasmodium falciparum
parasite biology to the clinic
04 Aug 2017
All it takes is a team. One goal keeper, two strikers and a reliable mid-field
04 Aug 2017
Malaria
03 Aug 2017
Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers
24 Jul 2017
Swiss Malaria Group Annual Report 2016
19 Jul 2017
Annual Report 2016
03 Jul 2017
Rapport de gestion 2016
03 Jul 2017
SMC forecasting platform: a tool to support SP+AQ availability
03 Jul 2017
The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergises with Quinoline-Derived Antimalarials
26 Jun 2017
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate
17 Jun 2017
Multiplex, DNase-free one-step reverse transcription PCR for
Plasmodium
18S rRNA and spliced gametocyte-specific mRNAs
19 May 2017
Antimalarial efficacy of MMV390048, an inhibitor of
Plasmodium
phosphatidylinositol 4-kinase
26 Apr 2017
Susceptibility Testing of Medically Important Parasites
26 Apr 2017
How Reagan beat severe malaria
25 Apr 2017
Discovery of a Novel Antifungal Agent in the Pathogen Box
12 Apr 2017
Plasmodium falciparum
K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness
In Vitro
11 Apr 2017
Challenges for achieving safe and effective radical cure of
Plasmodium vivax
: a round table discussion of the APMEN Vivax Working Group
07 Apr 2017
DSM265 for
Plasmodium falciparum
chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection
28 Mar 2017
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
28 Mar 2017
Identifying the need for new drugs – Opening doors
20 Mar 2017
Addressing challenges to antimalarial access and malaria case management
14 Mar 2017
Managing intellectual property to develop medicines for the world’s poorest
24 Feb 2017
Stereochemical Aspects of T3P Amidations
21 Feb 2017
G-Finder 2016
16 Feb 2017
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents
14 Feb 2017
The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic Screens
08 Feb 2017
Substrate-analogous inhibitors exert antimalarial action by targeting the
Plasmodium
lactate transporter PfFNT at nanomolar scale
08 Feb 2017
A novel in vitro image-based assay identifies new drug leads for giardiasis
27 Jan 2017
In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate
25 Jan 2017
New developments in anti-malarial target candidate and product profiles
13 Jan 2017
SAR of the Antimalarial Ozonide Artefenomel (OZ439)
04 Jan 2017
Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated
Plasmodium falciparum
malaria in real-life conditions of use in Côte d’Ivoire
03 Jan 2017
How to tackle antimalarial resistance?
27 Dec 2016
Control and Elimination of
Plasmodium vivax
Malaria: The Evidence Base
22 Dec 2016
World Malaria Report 2016
13 Dec 2016
Novel inhibitors of
Plasmodium falciparum
based on 2,5-disubstituted furans
11 Dec 2016
Identification of inhibitors that dually target the new permeability pathway and dihydroorotate dehydrogenase in the blood stage of
Plasmodium falciparum
22 Nov 2016
Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with
Plasmodium Falciparum
Parasitemia: An Open-Label, Non-Comparative Study in Sub- Saharan Africa
18 Nov 2016
Putting children and mothers first
16 Nov 2016
MMV at a Glance
31 Oct 2016
The role of intellectual property in the battle against malaria
28 Oct 2016
Screening the Pathogen Box for Identification of Candida albicans Biofilm Inhibitors
24 Oct 2016
Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action
21 Oct 2016
Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways
21 Oct 2016
Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial
20 Oct 2016
Identification of a Potential Antimalarial Drug Candidate from a Series of 2‑Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle
17 Oct 2016
Diagnosis and Treatment of
Plasmodium vivax
Malaria
05 Oct 2016
Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose–Efficacy Modeling
04 Oct 2016
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-piperaquine or Artemether-lumefantrine in Healthy Adult Subjects
03 Oct 2016
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
28 Sep 2016
A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
17 Sep 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles
14 Sep 2016
A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early
Plasmodium falciparum
in an induced blood stage malaria infection study
13 Sep 2016
Defining the Effectiveness of Antimalarial Chemotherapy: Investigation of the Lag in Parasite Clearance Following Drug Administration
01 Sep 2016
Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways
29 Aug 2016
Open data in drug discovery and development: lessons from malaria
12 Aug 2016
Hit-to-lead studies for the antimalarial tetrahydroisoquinolone carboxanilides
09 Aug 2016
Screening of the ‘Pathogen Box’ identifies an approved pesticide with major anthelmintic activity against the barber's pole worm
28 Jul 2016
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
28 Jul 2016
Pages
1
2
3
4
5
6
7
8
9
next ›
last »
